Bicycle Therapeutics plc (BCYC) Tops Q2 EPS by 36c
Tweet
Share
E-mailGet Alerts BCYC Hot Sheet
Join SI Premium – FREE
Bicycle Therapeutics plc (NASDAQ: BCYC) reported Q2 EPS of ($0.77), $0.36 better than the analyst estimate of ($1.13). Revenue for the quarter came in at $9.36 million versus the consensus estimate of $6.13 million.
For earnings history and earnings-related data on Bicycle Therapeutics plc (BCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Lazard Global Total Return fund declares $0.1534 monthly distribution
- loanDepot receives NYSE non-compliance notice over stock price
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
